|
°¡½ÎÀ̹ÙÁÖ(¿Àºñ´©ÅõÁÖ¸¿, À¯ÀüÀÚÀçÁ¶ÇÕ) 40mL | obinutuzumab 1g | Àü¹® | ±Þ¿© |
|
·ÎÁñ¸®Æ®·ºÄ¸½¶100mg(¿£Æ®·ºÆ¼´Õ) | entrectinib 100mg | Àü¹® | ±Þ¿© |
|
·ÎÁñ¸®Æ®·ºÄ¸½¶200mg(¿£Æ®·ºÆ¼´Õ) | entrectinib 200mg | Àü¹® | ±Þ¿© |
|
·é¼ö¹Ì¿ÀÁÖ(¸ð¼ö³×ÅõÁÖ¸¿) 1mL | Mosunetuzumab 1mg | Àü¹® | ºñ±Þ¿© |
|
·é¼ö¹Ì¿ÀÁÖ(¸ð¼ö³×ÅõÁÖ¸¿) 30mL | Mosunetuzumab 30mg | Àü¹® | ºñ±Þ¿© |
|
¸¶µµÆÄ¿¡Ãëºñ¿¡½ºÄ¸½¶125 | Levodopa 100mg ¿Ü 1°³ | Àü¹® | ±Þ¿© |
|
¸¶µµÆÄÈ®»êÁ¤125 | Levodopa 100mg ¿Ü 1°³ | Àü¹® | ±Þ¿© |
|
¸¿Å׶óÁÖ(¸®Åö½Ã¸¿) 10mL | Rituximab 100mg | Àü¹® | ±Þ¿© |
|
¸¿Å׶óÁÖ(¸®Åö½Ã¸¿) 50mL | Rituximab 500mg | Àü¹® | ±Þ¿© |
|
¸¿Å׶óÇÇÇÏÁÖ»ç(¸®Åö½Ã¸¿) 11.7mL | Rituximab 1400mg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ100¥ìg/0.3mL | methoxy polyethylene glycol-epoetin ¥â 100¥ìg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ120¥ìg/0.3mL | methoxy polyethylene glycol-epoetin ¥â 120¥ìg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ150¥ìg/0.3mL | methoxy polyethylene glycol-epoetin ¥â 150¥ìg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ200¥ìg/0.3mL | methoxy polyethylene glycol-epoetin ¥â 200¥ìg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ250¥ìg/0.3mL | methoxy polyethylene glycol-epoetin ¥â 250¥ìg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ360¥ìg/0.6mL | methoxy polyethylene glycol-epoetin ¥â 360¥ìg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ50¥ìg/0.3mL | methoxy polyethylene glycol-epoetin ¥â 50¥ìg | Àü¹® | ±Þ¿© |
|
¹Ì½ê¶óÇÁ¸®ÇʵåÁÖ75¥ìg/0.3mL | methoxy polyethylene glycol-epoetin ¥â 75¥ìg | Àü¹® | ±Þ¿© |
|
¹Ùºñ½º¸ðÁÖ(Æĸ®½Ã¸¿) 0.24mL | Faricimab 28.8mg | Àü¹® | ±Þ¿© |
|
»ç¸®µ·¿¡ÀÌÁ¤ | Isopropylantipyrine 150MG ¿Ü 2°³ | ÀÏ¹Ý | ºñ±Þ¿© |